Media
Company news
#BIO2024!
#BIO2024!
Thank you to everyone who visited us at the ChemDiv, Inc. booth in the California Pavilion.
Thank you to everyone who visited us at the ChemDiv, Inc. booth in the California Pavilion.
Pop-Science
Novel Potent TIM-3 Inhibitors were discovered in ChemDiv’s collection.
The ChemDiv’s proprietary library of chemically diverse small molecule compounds was demonstrated to be a source of selective inhibitors targeting specific check points was found out in a recen...
ChemDiv in Publications
ChemDiv Company in publications and patents
We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area.
It means a lot to us if our custome...
Pharma News
Merck gains rights to LaNova’s PD-1/VEGF bispecific antibody in deal worth over $3.2bn
Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over $3.2bn to advance LaNova Medicines’ investigational PD-1/VEGF bispecific...
Follow us: